Konsume
Interval Day Week Month
Range 30 Day 90 Day 6 Months 1 Yr
Author Profile Past 90 Days 18 stories 1 Publishers

frank vinluan

No author bio on file yet.

Social profiles not yet on file.
frank vinluan's Coverage
Buzz
Media Coverage
World View
Beat Reporting
Category Articles Share
Health_Medical_Pharma 15
Business_Finance 2

Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer
2026-06-04 — medcitynews.com


Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was
2026-06-03 — medcitynews.com


FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug
2026-06-02 — medcitynews.com


Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
2026-06-01 — medcitynews.com


Regeneron Cancer Drug Shows New Promise in a Rare Disease… and Maybe More
2026-05-31 — medcitynews.com


Pfizer’s $10.5B Deal With One of China’s Top Cancer Biotechs Is Another Sign the Game is Changing
2026-05-29 — medcitynews.com


AbbVie’s ADC Strategy Notches Another Win With FDA Approval in Ultra-Rare Blood Cancer
2026-05-28 — medcitynews.com


Apogee’s Royalty Deal With Blackstone Will Fund Pivotal Test in Eczema and More
2026-05-27 — medcitynews.com


Eli Lilly’s Vaccine Acquisitions Signal a Strategy of Growth in New Areas
2026-05-26 — medcitynews.com


AstraZeneca, Daiichi Drug Approved as New First-Line Therapy for Tough Type of Breast Cancer
2026-05-25 — medcitynews.com

Execution: 0.03 Seconds. 36 mb used.